Robin Lloyd is a freelance writer, editor and educator, as well as a contributing editor for Scientific American and an adjunct professor at New York University’s Science, Health and Environmental Reporting Program. She has a Ph.D. and M.A. in sociology from the University of California, Santa Barbara, and a B.A. from Smith College. She completed a Knight Science Journalism Fellowship at the Massachusetts Institute of Technology for the 1998-1999 academic year.
Robin Lloyd
Locum News Editor
Spectrum
From this contributor
Sounding out ultrasounds; name game; geek gathering
A tie between first-trimester ultrasounds and autism severity is tenuous at best, misnamed genes litter the literature, and neuroscientists enjoy their version of summer camp.
Sounding out ultrasounds; name game; geek gathering
By
Robin Lloyd
9 September 2016 | 5 min read
Calming remedies; labor lessons; women wanted
New drugs target the brain’s calming chemical, inducing labor does not boost autism risk, and the start is imminent for a project to develop personalized treatments.
Fake facilitation; third strike; Pokémon passion
An autism researcher retracts her third paper in as many years, scientists write fraudulent reviews of their own papers, and Pokémon Go boosts social skills in children with autism.
Brexit break-ups; little impact; micro medicine
Scientists are excluding U.K. colleagues from studies; a life sciences publisher abandons the ‘impact factor;’ and a new open-access journal makes its debut.
CRISPR medicine; inclusive experiments; autism in Egypt
Scientists target human cancer with CRISPR, device trials may become more diverse, and autism awareness grows in Egypt.
CRISPR medicine; inclusive experiments; autism in Egypt
By
Robin Lloyd
24 June 2016 | 4 min read
Explore more from The Transmitter
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
By
Holly Barker
8 July 2026 | 5 min read